Immunocore Holdings Plc ADR
(IMCR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,052 | -24,436 | -55,287 | -35,557 | -36,463 |
| Depreciation Amortization | 2,003 | 1,011 | 4,090 | 3,058 | 1,981 |
| Accounts receivable | -8,861 | -6,198 | -17,871 | -7,647 | -7,176 |
| Accounts payable and accrued liabilities | 2,164 | -2,320 | 2,625 | -1,130 | 2,962 |
| Other Working Capital | 35,364 | 8,140 | 5,782 | 26,496 | 15,735 |
| Other Operating Activity | 24,267 | 19,216 | 63,601 | 35,453 | 33,545 |
| Operating Cash Flow | $18,885 | $-4,587 | $2,940 | $20,673 | $10,584 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -350,000 | N/A | N/A | N/A | N/A |
| PPE Investments | -761 | -430 | -5,425 | -4,608 | -4,396 |
| Investing Cash Flow | $-350,761 | $-430 | $-5,425 | $-4,608 | $-4,396 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 402,500 | 402,500 | N/A | N/A | N/A |
| Common Stock Issued | 6,052 | 5,754 | 34,346 | 28,092 | 17,716 |
| Other Financing Activity | -13,358 | -12,242 | 0 | 0 | 0 |
| Financing Cash Flow | $395,194 | $396,012 | $34,346 | $28,092 | $17,716 |
| Exchange Rate Effect | -959 | -800 | 8,293 | -2,491 | 5,619 |
| Beginning Cash Position | 442,626 | 442,626 | 402,472 | 402,472 | 402,472 |
| End Cash Position | 504,985 | 832,821 | 442,626 | 444,138 | 431,995 |
| Net Cash Flow | $62,359 | $390,195 | $40,154 | $41,666 | $29,523 |
| Free Cash Flow | |||||
| Operating Cash Flow | 18,885 | -4,587 | 2,940 | 20,673 | 10,584 |
| Capital Expenditure | -761 | -430 | -5,425 | -4,608 | -4,396 |
| Free Cash Flow | 18,124 | -5,017 | -2,485 | 16,065 | 6,188 |